Brief: GoodRx Holdings Q1 Adjusted Net Income USD 23 Million Vs. IBES Estimate USD 24.7 Million
May 06 (Reuters) - GoodRx Holdings Q1 revenue USD 194 million vs. IBES estimate USD 185.4 million. Q1 adjusted EBITDA USD 58.3 million vs. IBES estimate USD 56.4 million Q1 net income USD 1.2 million Q1 adjusted EBITDA margin 30%
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million